Plant Health Care to present at Mello London

Plant Health Care plc (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, has today announced it has successfully submitted its application to the regulatory agencies in Brazil for approval to commercialize

Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, has today provided the following update on trading in Brazil further to the Trading Update on 19 December 2019. Plant

Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today provided the following update on trading in 2019. Chris Richards, CEO of Plant Health Care noted: “In 2019, as

Plant Health Care (LON:PHC) has announced three new Board appointments with effect from 1st November 2019. Mr Guy van Zwanenberg FCA will join the PHC Board as a Non-executive Director. He will take over as Chair of the

Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, has today provided the following update in relation to the 2018/19 field trials of the PREtec peptide PHC279 for the

Plant Health Care (LON: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, announced today its preliminary results for the full year ended 31 December 2018. Chris Richards, Plant Health Care Executive

Chris Richards, Plant Healthcare Executive Chairman & Interim CEO, said: “We are excited about the potential for the product pipeline now coming out of our PREtec technology. These products are targeting very large markets, which have

Chris Richards, Plant Health Care Interim CEO, commented: “Plant Health Care continued to make exciting progress in 2018, in spite of recently announced set-backs. The launch of our new corn product in the US holds great

Chris Richards, Plant Health Care Executive Chairman & Interim CEO, said “As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our range of partners who will evaluate

Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: “This award is recognition that Plant Health Care, as a science-based company, can bring new benefits to growers with low toxicity, biological products. We

Chris Richards, Executive Chairman and Interim CEO of Plant Health Care, noted: “Grower reaction to demonstration trials of H2Copla has been very positive. Growers have already treated some 20,000 Ha of sugarcane with the product. The